Shoumariyeh K, Csernalabics B, Salimi Alizei E, Reinscheid M, Giese S, Ciminski K
Vaccines (Basel). 2024; 12(11).
PMID: 39591152
PMC: 11598869.
DOI: 10.3390/vaccines12111249.
Wongnak R, Brindha S, Oba M, Yoshizue T, Islam M, Islam M
Molecules. 2024; 29(11).
PMID: 38893549
PMC: 11173568.
DOI: 10.3390/molecules29112676.
Wu L, Park S, Jakobsson H, Shackleton M, Moller A
Cancers (Basel). 2024; 16(11).
PMID: 38893071
PMC: 11171058.
DOI: 10.3390/cancers16111950.
Ahmed H, Mahmud A, Siddiquee M, Shahriar A, Biswas P, Shimul M
Cancer Pathog Ther. 2024; 1(2):116-126.
PMID: 38328405
PMC: 10846312.
DOI: 10.1016/j.cpt.2022.12.002.
Tu H, Kung Y, Lim L, Tao J, Hu M, Cheng M
J Biomed Sci. 2024; 31(1):19.
PMID: 38287325
PMC: 10826030.
DOI: 10.1186/s12929-024-01006-9.
Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer.
Kotwal A, Gustafson M, Bornschlegl S, Dietz A, Delivanis D, Ryder M
Front Immunol. 2024; 14:1325343.
PMID: 38235146
PMC: 10792034.
DOI: 10.3389/fimmu.2023.1325343.
Isolation of tumour-reactive lymphocytes from peripheral blood via microfluidic immunomagnetic cell sorting.
Wang Z, Ahmed S, Labib M, Wang H, Wu L, Bavaghar-Zaeimi F
Nat Biomed Eng. 2023; 7(9):1188-1203.
PMID: 37037966
DOI: 10.1038/s41551-023-01023-3.
Tissue-resident memory T cells and lung immunopathology.
Cheon I, Son Y, Sun J
Immunol Rev. 2023; 316(1):63-83.
PMID: 37014096
PMC: 10524334.
DOI: 10.1111/imr.13201.
The Immunogenicity of DENV1-4 ED3s Strongly Differ despite Their Almost Identical Three-Dimensional Structures and High Sequence Similarities.
Islam M, Sharmin T, Tipo I, Saha A, Yesmin S, Roy M
Int J Mol Sci. 2023; 24(3).
PMID: 36768719
PMC: 9916489.
DOI: 10.3390/ijms24032393.
Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases.
Carbone F
Nat Rev Immunol. 2022; 23(5):329-335.
PMID: 36494455
PMC: 9735123.
DOI: 10.1038/s41577-022-00815-z.
Inefficient Recovery of Repeatedly Stimulated Memory CD8 T Cells after Polymicrobial Sepsis Induction Leads to Changes in Memory CD8 T Cell Pool Composition.
Moioffer S, Berton R, McGonagill P, Jensen I, Griffith T, Badovinac V
J Immunol. 2022; 210(2):168-179.
PMID: 36480268
PMC: 9840817.
DOI: 10.4049/jimmunol.2200676.
Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine.
Luan N, Cao H, Wang Y, Lin K, Liu C
Pharmaceutics. 2022; 14(5).
PMID: 35631559
PMC: 9143440.
DOI: 10.3390/pharmaceutics14050973.
A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8 T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice.
Vu P, Vadakekolathu J, Idri S, Nicholls H, Cavaignac M, Reeder S
Cancers (Basel). 2022; 14(8).
PMID: 35454873
PMC: 9032647.
DOI: 10.3390/cancers14081970.
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers.
Molinos-Albert L, Lorin V, Monceaux V, Orr S, Essat A, Dufloo J
Nat Commun. 2022; 13(1):1944.
PMID: 35410989
PMC: 9001681.
DOI: 10.1038/s41467-022-29511-1.
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution.
Gil-Etayo F, Garcinuno S, Utrero-Rico A, Cabrera-Marante O, Arroyo-Sanchez D, Mancebo E
Biomedicines. 2022; 10(2).
PMID: 35203509
PMC: 8869678.
DOI: 10.3390/biomedicines10020296.
Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa.
Tang J, Cai L, Xu C, Sun S, Liu Y, Rosenecker J
Nanomaterials (Basel). 2022; 12(2).
PMID: 35055244
PMC: 8777913.
DOI: 10.3390/nano12020226.
Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy.
Cao H, Wang Y, Luan N, Lin K, Liu C
Vaccines (Basel). 2021; 9(12).
PMID: 34960186
PMC: 8704662.
DOI: 10.3390/vaccines9121440.
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.
Mok C, Cohen C, Cheng S, Chen C, Kwok K, Yiu K
Respirology. 2021; 27(4):301-310.
PMID: 34820940
PMC: 8934254.
DOI: 10.1111/resp.14191.
A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC.
Lopez M, Vinzon S, Cafferata E, Nunez F, Soto A, Sanchez-Lamas M
Vaccines (Basel). 2021; 9(10).
PMID: 34696219
PMC: 8537385.
DOI: 10.3390/vaccines9101106.
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response.
Ngamcherdtrakul W, Reda M, Nelson M, Wang R, Zaidan H, Bejan D
Adv Mater. 2021; 33(31):e2100628.
PMID: 34118167
PMC: 8424660.
DOI: 10.1002/adma.202100628.